A Study on the Outcome Management Plan of Integrated Traditional Chinese and Western Medicine Treatment for Spastic Cerebral Palsy in Children

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2300073883

Enrollment

Unknown

Registered

2023-07-24

Start date

2023-08-01

Completion date

Unknown

Last updated

2023-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children with spastic cerebral palsy

Interventions

Outcome Management treatment group:NA

No outcome Management treatment group:NA

Eligibility

Sex/Gender

All

Age

No minimum to 18 Years

Inclusion criteria

Inclusion criteria: (1) Conform to the diagnostic criteria for spastic cerebral palsy in children in the Chinese Guidelines for Rehabilitation of Cerebral Palsy (2022); (2) Patients who have not participated in other scientific research trials that may affect the results of this study; (3) Those who can cooperate with clinical physicians or rehabilitation physicians to complete the experiment; (4) Informed consent and voluntary participation in this experiment. All inclusion criteria mentioned above must be met simultaneously in order to be included in the experiment.

Exclusion criteria

Exclusion criteria: (1) Patients with severe congenital diseases, such as Congenital heart defect and congenital genetic metabolic diseases; (2) Patients with clear surgical indications that require surgical treatment and are not suitable for continuing the trial; (3) Those who are not suitable for rehabilitation treatment due to the merger of other diseases, or those who are suspected and diagnosed with intraspinal tumors, infections, or tuberculosis; Or those with serious heart disease, Chronic obstructive pulmonary disease, liver and kidney function impairment and other medical diseases; (4) Those with Mental disorder and other diseases, or who can not cooperate with the test in other circumstances, or who refuse to participate in this topic; If one of the above criteria is met, the patient will not be included in the trial.

Design outcomes

Primary

Measure	Time frame
Gross Motor Function Measure,GMFM;Modified Ashworth Scale,MAS;Functional Independence Measure,WeeFIM;	—

Secondary

Measure	Time frame
Wechsler Intelligence Scale,WIS;The Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales,PedsQL4.0;sign-significate relations,S-S;cost-benefit analysis;	—

Countries

China

Contacts

Public ContactLIU Jia

Institute Of Basic Research In Clinical Medicine,China Academy Of Chinese Medical Sciences

marie_liujia@sina.cn+86 188 1087 7011

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026